NCT02193581View on ClinicalTrials.gov

Non-invasive Melanoma Assessment Using a Topical Fluorescence Reagent and Optical Imaging

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

August 30, 2017

Primary Completion Date

December 1, 2017

Study Completion Date

December 1, 2017

Conditions
Skin Lesion
Interventions
DEVICE

MDS

Patients with a suspicious lesion, referred for a biopsy is tested using MDS.

Trial Locations (1)

Unknown

Hadassah Medical Organization, Jerusalem

Sponsors

Lead Sponsor

Orlucent, Inc
All Listed Sponsors
collaborator

Hadassah Medical Organization

OTHER

lead

Orlucent, Inc

INDUSTRY